Nov 2018

MEDICINAL CANNABIS STILL TOO EXPENSIVE FOR MANY AUSTRALIAN PATIENTS

A new survey has found that even though the cost of medicinal cannabis has significantly decreased over the past year the pricing is still too high for many Australians. Patients are required to cover all of the cost of their treatment as no cannabis medications are subsidised by the Pharmaceutical Benefits Scheme (PBS). As a result many of them are looking for cheaper alternatives on the black market. Read the article here.

Australian Natural Therapeutics Group (ANTG) will ship locally cultivated and […]

READ MORE >

Two medicinal marijuana companies have fast-tracked plans to build a […]

READ MORE >

ANTG APPOINTS JUSTIN SINCLAIR AS CHIEF SCIENTIFIC OFFICER Australian Natural […]

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >